Blanket Purchase Agreement HT001120A0001

The Defense Health Agency awarded a blanket purchase agreement to Blood Centers of America, Inc. for the delivery of COVID-19 convalescent plasma. Under the single award agreement and associated task orders, Blood Centers of America will provide convalescent plasma valued at $8.789 million to support the Department of Defense's response to the COVID-19 pandemic. Performance will take place at Blood Centers of America's facility in Mosby, Virginia through November 30, 2021.

The task orders issued against the blanket purchase agreement include a $400,000 order for convalescent plasma to be delivered by September 12, 2020, a $514,000 order for COVID-19 convalescent plasma with performance through June 19, 2020, and a $1.875 million order for COVID-19 convalescent plasma with a one month period of performance from June 1, 2020 to July 2, 2020. The original solicitation sought convalescent plasma to treat COVID-19 patients as part of the Defense Health Agency's mission to ensure military medical readiness and manage impacts of the COVID-19 national emergency. No subcontractors or socioeconomic set asides were specified.